Galapagos NV
GLPG
#4589
Rank
A$3.13 B
Marketcap
A$47.55
Share price
-0.12%
Change (1 day)
29.72%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: A$3.13 Billion

As of February 2026 Galapagos NV has a market cap of A$3.13 Billion. This makes Galapagos NV the world's 4589th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.13 B-3.57%
2025A$3.24 B12.35%
2024A$2.89 B-26.44%
2023A$3.93 B-8.43%
2022A$4.29 B-14.79%
2021A$5.03 B-40.16%
2020A$8.42 B-56.36%
2019A$19.29 B170.83%
2018A$7.12 B15.82%
2017A$6.15 B48.8%
2016A$4.13 B22.17%
2015A$3.38 B385.23%
2014A$0.69 B-0.75%
2013A$0.70 B29.21%
2012A$0.54 B56.33%
2011A$0.34 B-16.94%
2010A$0.41 B47.6%
2009A$0.28 B94.81%
2008A$0.14 B

End of Day market cap according to different sources

On Feb 10th, 2026 the market cap of Galapagos NV was reported to be:

A$3.13 Billion
by Nasdaq info icon info icon
A$3.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$809.89 B 25,744.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$273.63 B 8,632.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$548.42 B 17,400.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$166.69 B 5,219.46%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$415.99 B 13,175.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$438.05 B 13,878.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$165.70 B 5,187.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A$0.15 B-95.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$55.93 B 1,685.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel